Illustrative image – not actual.Neogen Chemicals has reported strong financial performance for the first quarter of FY27, with consolidated revenue rising 34 percent year-on-year to Rs 250 crore.
The company achieved growth despite a temporary shutdown at its Dahej plant, supported by efficient management of toll manufacturing facilities and higher volumes across key product categories. The Organolithium portfolio delivered significant gains due to improved plant throughput. Neogen Ionics' (NIL) performance was driven by favourable product mix and record performance in organolithium, battery chemicals, and inorganic chemicals. The company’s Board has approved raising up to Rs 600 crore through eligible securities via a Qualified Institutional Placement (QIP), subject to shareholder and statutory approvals.
Neogen Ionics’ Dahej Phase 1 and Pakhajan Phase 2 Battery Materials projects have a combined estimated cost of Rs 1,795 crore, with completion targeted by 2027. Electrolyte facilities are progressing with trial runs initiated, while lithium electrolyte salts have secured provisional approvals from international customers.
